Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Max Power Prepares to Drill Second Natural Hydrogen Well as Program Expands 325 km SW of Lawson Discovery

January 30, 2026

HPQ Confirms Fumed Silica Produced With Pilot Scale Reactor is Independently Verified as Meeting Commercial Grade “150”

January 30, 2026

HVAC Rooftop Units Industry Forecast to 2033

January 30, 2026

Cavli Cat 1bis Modules: Multi-Form-Factor Connectivity for Diverse IoT Applications

January 30, 2026

Luvme Hair Introduces All-Day Curl Hold™ Wig for Long-Lasting Curl Definition

January 30, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » $5.66 Bn Precision Medicine Software Market Forecast to 2033
Press Release

$5.66 Bn Precision Medicine Software Market Forecast to 2033

By News RoomJanuary 30, 20263 Mins Read
.66 Bn Precision Medicine Software Market Forecast to 2033
Share
Facebook Twitter LinkedIn Pinterest Email
.66 Bn Precision Medicine Software Market Forecast to 2033

Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) — The “Precision Medicine Software Market Forecast to 2033” has been added to ResearchAndMarkets.com’s offering.

The global precision medicine software market, valued at USD 2.12 billion in 2024, is projected to soar to USD 5.66 billion by 2033, reflecting a robust CAGR of 11.8% from 2025 to 2033.

This significant growth is driven by the decreasing costs of genome sequencing, escalating demand for targeted therapies, expanding decentralized trials, and the integration of real-world evidence. Government and institutional endorsements of genomics and precision medicine are further bolstering market expansion.

Beyond lowering costs, genome sequencing has evolved from a complex research endeavor into a standard clinical practice, thereby propelling the precision medicine software sector. Previously, a genome sequencing task was prohibitively expensive, costing nearly USD 100 million in the early 2000s. The cost has now plummeted to under USD 500, facilitating widespread adoption across hospitals, diagnostic labs, pharmaceutical companies, and consumer health organizations. This affordability has led to a dramatic rise in large-scale genomic testing, producing extensive datasets that necessitate sophisticated software solutions for effective storage, integration, and interpretation.

Precision medicine software is crucial in transforming raw genomic data into practical clinical insights, essential for diagnosis, therapy selection, and patient stratification. The demand for such software is escalating as genome sequencing becomes a staple in oncology, rare disease management, and preventive healthcare.

Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2024 – 2033
Estimated Market Value (USD) in 2024 $2.12 Billion
Forecasted Market Value (USD) by 2033 $5.66 Billion
Compound Annual Growth Rate 11.8%
Regions Covered Global

Key Topics Covered:

  • Market Segmentation & Scope
  • Segment Definitions
  • Estimates and Forecast Timeline
  • Research Methodology
  • Information Procurement
  • Information Analysis
  • Market Formulation & Data Visualization
  • Model Details
  • List of Secondary Sources
  • Objectives
  • Market Snapshot
  • Segment Snapshot
  • Competitive Landscape Snapshot
  • Market Lineage Outlook
  • Market Dynamics
  • Business Environment Analysis

Companies Featured

  • OSP
  • Genomind
  • IQVIA
  • Genedata AG
  • SOPHiA GENETICS
  • Tempus AI, Inc.
  • Owkin, Inc
  • Syapse (acquired by N-Power in January 2025)
  • Inspirata, Inc.
  • Precision Medicine Group, LLC.
  • Siemens
  • GenomOncology LLC
  • Qserve
  • Foundation Medicine, Inc.
  • PierianDx

Global Precision Medicine Software Market Report Segmentation

Component Outlook (Revenue, USD Million, 2021-2033)

Deployment Mode Outlook (Revenue, USD Million, 2021-2033)

Application Outlook (Revenue, USD Million, 2021-2033)

  • Genomic Data Management & Analysis
  • Multi-omics Analytics
  • Clinical Decision Support & Treatment Planning
  • Companion Diagnostics & Biomarker Discovery Tools
  • Clinical Trial Matching & Site Selection
  • Others (Population Genomics / Public-health Precision Tools)

Technology Outlook (Revenue, USD Million, 2021-2033)

  • AI / Machine Learning models & Generative AI
  • Rule-based engines
  • Cloud & Containerized Pipelines
  • High-performance compute for genomics
  • Interoperability / FHIR / HL7 integration
  • Others

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Cardiology
  • Neurology / CNS
  • Rare & Genetic Disorders
  • Infectious Diseases
  • Immunology / Autoimmune
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Pharmaceutical & Biotech companies
  • Diagnostic Laboratories & Genomic Service Providers
  • Contract Research Organizations (CROs)
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

For more information about this report visit https://www.researchandmarkets.com/r/j2g8w9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Precision Medicine Software Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Max Power Prepares to Drill Second Natural Hydrogen Well as Program Expands 325 km SW of Lawson Discovery

HPQ Confirms Fumed Silica Produced With Pilot Scale Reactor is Independently Verified as Meeting Commercial Grade “150”

HVAC Rooftop Units Industry Forecast to 2033

Cavli Cat 1bis Modules: Multi-Form-Factor Connectivity for Diverse IoT Applications

Luvme Hair Introduces All-Day Curl Hold™ Wig for Long-Lasting Curl Definition

Alamos Gold Extends Higher-Grade Mineralization within Multiple Hanging Wall Zones Near Existing Infrastructure at Young-Davidson

With Halborn Audit and V1 Protocol Activated Mutuum Finance (MUTM) Raises Over $20M Since Q1 2025

Smart Home Pet Products Market Report 2026-2030 and 2035

BingX AI Bingo Integrates TradFi Suite to Expand Intelligent, Multi-Asset Trading

Editors Picks

HPQ Confirms Fumed Silica Produced With Pilot Scale Reactor is Independently Verified as Meeting Commercial Grade “150”

January 30, 2026

HVAC Rooftop Units Industry Forecast to 2033

January 30, 2026

Cavli Cat 1bis Modules: Multi-Form-Factor Connectivity for Diverse IoT Applications

January 30, 2026

Luvme Hair Introduces All-Day Curl Hold™ Wig for Long-Lasting Curl Definition

January 30, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Alamos Gold Extends Higher-Grade Mineralization within Multiple Hanging Wall Zones Near Existing Infrastructure at Young-Davidson

January 30, 2026

With Halborn Audit and V1 Protocol Activated Mutuum Finance (MUTM) Raises Over $20M Since Q1 2025

January 30, 2026

Smart Home Pet Products Market Report 2026-2030 and 2035

January 30, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version